Literature DB >> 17081697

Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis.

K Xu1, S Jha, W Hoch, S E Dryer.   

Abstract

Myasthenia gravis can be induced in mice by injecting the extracellular domain of rat muscle-specific kinase (MuSK), a transmembrane receptor tyrosine kinase involved in agrin signaling at the neuromuscular junction. About 5-10% of human myasthenia gravis patients have autoantibodies against MuSK. Here we have examined mouse neuromuscular junctions following MuSK immunization in two groups of muscles that can be distinguished on the basis of the timing of neuromuscular synaptogenesis and their response to perturbation of agrin signaling. We used confocal microscopy to characterize the distribution and expression of nicotinic acetylcoline receptors and of two presynaptic makers, neurofilament protein and synaptophysin. We observed disruption of neuromuscular junctions in all muscles examined in this model of myasthenia gravis. However delayed-synapsing muscles, including the diaphragm, sternomastoid and tibialis posterior, were significantly more severely affected than fast-synapsing muscles, including the intercostal, adductor longus and tibialis anterior. These results suggest a basis for the differential susceptibility of muscles in different classes of myasthenia gravis patients, including patients with autoantibodies against MuSK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081697     DOI: 10.1016/j.neuroscience.2006.09.022

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

2.  Anti-MuSK autoantibodies block binding of collagen Q to MuSK.

Authors:  Y Kawakami; M Ito; M Hirayama; K Sahashi; B Ohkawara; A Masuda; H Nishida; N Mabuchi; A G Engel; K Ohno
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

3.  Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy.

Authors:  Karen K Y Ling; Rebecca M Gibbs; Zhihua Feng; Chien-Ping Ko
Journal:  Hum Mol Genet       Date:  2011-10-03       Impact factor: 6.150

4.  Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.

Authors:  R N Cole; N Ghazanfari; S T Ngo; O L Gervásio; S W Reddel; W D Phillips
Journal:  J Physiol       Date:  2010-07-05       Impact factor: 5.182

5.  Neuromuscular junction pathology is correlated with differential motor unit vulnerability in spinal and bulbar muscular atrophy.

Authors:  Elana Molotsky; Yuhong Liu; Andrew P Lieberman; Diane E Merry
Journal:  Acta Neuropathol Commun       Date:  2022-07-05       Impact factor: 7.578

6.  Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

7.  MHCI promotes developmental synapse elimination and aging-related synapse loss at the vertebrate neuromuscular junction.

Authors:  Mazell M Tetruashvily; Marin A McDonald; Karla K Frietze; Lisa M Boulanger
Journal:  Brain Behav Immun       Date:  2016-01-21       Impact factor: 7.217

8.  Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.

Authors:  Giovanna Cenacchi; Valentina Papa; Papa Valentina; Marina Fanin; Fanin Marina; Elena Pegoraro; Pegoraro Elena; Corrado Angelini; Angelini Corrado
Journal:  J Neurol       Date:  2010-11-19       Impact factor: 4.849

9.  MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.

Authors:  Inga Koneczny; Judith Cossins; Patrick Waters; David Beeson; Angela Vincent
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

10.  Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis.

Authors:  Nazanin Ghazanfari; Erna L T B Linsao; Sofie Trajanovska; Marco Morsch; Paul Gregorevic; Simon X Liang; Stephen W Reddel; William D Phillips
Journal:  Physiol Rep       Date:  2015-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.